English
Inquiries
May 21,2025 Toagosei Announces Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation to Directors and Other Persons
May 14,2025 Financial Results for 1Q FY2025
May 13,2025 Toagosei and Innovation Center of NanoMedicine (iCONM) Announce the Conclusion of a Collaborative Research Agreement on an Innovative siRNA Medication for Triple-negative Breast Cancer Treatment [PDF:4.1 MB]
May 21,2025 Toagosei Announces Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation to Directors and Other Persons [PDF:100.3 KB]
May 14,2025 Financial Results for 1Q FY2025 [PDF:956.2 KB]
May 19,2025 Revision to the Price of Ferric Chloride (FeCl₃) Solution and Ferrous Chloride (FeCl₂) Solution [PDF:132.2 KB]
March 07,2025 Financial Results for FY2024 Manuscript of Presentation (Including Q&A Session)
January 27,2025 Revision to the Price of Aronix Products [PDF:165.6 KB]
Introducing Toagosei's businesses
Commodity Chemicals
Polymer and Oligomer Business
Adhesive Material Business
Performance Chemicals
Plastics Business
Information technology
Home electronics
Environment and energy
Basic materials
Automobiles
Lifestyle
Social infrastructure and residences
Pharmaceuticals and medical care
TOAGOSEI at a Glance
About Us
Investor Relations
Sustainability
Research and Development
